Prognostic significance of Ki67 proliferation index, HIF1 alpha index and microvascular density in patients with non-small cell lung cancer brain metastases

[1]  D. Rades,et al.  A new survival score for patients with brain metastases from non-small cell lung cancer , 2013, Strahlentherapie und Onkologie (Print).

[2]  J. Pichler,et al.  Extent of peritumoral brain edema correlates with prognosis, tumoral growth pattern, HIF1a expression and angiogenic activity in patients with single brain metastases , 2012, Clinical and Experimental Metastasis.

[3]  R. Stahel,et al.  Survival of patients treated surgically for synchronous single-organ metastatic NSCLC and advanced pathologic TN stage. , 2012, Lung cancer.

[4]  P. Lambin,et al.  Radical Treatment of Non–Small-Cell Lung Cancer Patients with Synchronous Oligometastases: Long-Term Results of a Prospective Phase II Trial (Nct01282450) , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[5]  G. Barnett,et al.  Impact of non-small cell lung cancer histology on survival predicted from the graded prognostic assessment for patients with brain metastases. , 2012, Lung cancer.

[6]  D. Rades,et al.  Do patients with a limited number of brain metastases need whole-brain radiotherapy in addition to radiosurgery? , 2012, Strahlentherapie und Onkologie.

[7]  Xianghua Luo,et al.  Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  I. Fidler.  The role of the organ microenvironment in brain metastasis. , 2011, Seminars in cancer biology.

[9]  S. Ha,et al.  Prognostic implications of hypoxia-inducible factor-1α in epidermal growth factor receptor-negative non-small cell lung cancer. , 2011, Lung cancer.

[10]  L. Collette,et al.  Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  A. Demir,et al.  Tumor angiogenesis in predicting the survival of patients with stage I lung cancer. , 2010, The Journal of thoracic and cardiovascular surgery.

[12]  R. Yamanaka.  Medical management of brain metastases from lung cancer (Review). , 2009, Oncology reports.

[13]  H. Heinzl,et al.  The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry , 2009, Journal of Neuro-Oncology.

[14]  N. Reinmuth,et al.  Prognostic relevance of angiogenesis in stage III NSCLC receiving multimodality treatment , 2009, European Respiratory Journal.

[15]  Y. Maehara,et al.  Upregulation of Hypoxia-Inducible Factor-1α mRNA and its Clinical Significance in Non-small Cell Lung Cancer , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[16]  Yoichi Watanabe,et al.  A validation study of a new prognostic index for patients with brain metastases: the Graded Prognostic Assessment. , 2008, Journal of neurosurgery.

[17]  M. Loda,et al.  Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinoma , 2008, Cancer.

[18]  S Wolfsberger,et al.  Ki67 index in intracranial ependymoma: a promising histopathological candidate biomarker , 2008, Histopathology.

[19]  Walter Curran,et al.  A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. , 2008, International journal of radiation oncology, biology, physics.

[20]  A. Grosu,et al.  The role of postoperative radiotherapy after resection of a single brain metastasis: Combined analysis of 497 patients , 2007 .

[21]  A. Grosu,et al.  The Role of Postoperative Radiotherapy after Resection of a Single Brain Metastasis , 2007, Strahlentherapie und Onkologie.

[22]  M. Babić,et al.  Non-small cell lung carcinoma: cyclin D1, bcl-2, p53, Ki-67 and HER-2 proteins expression in resected tumors. , 2007, Bosnian journal of basic medical sciences.

[23]  A. Harris,et al.  Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data. , 2007, The Lancet. Oncology.

[24]  S. Hassenbusch,et al.  Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis , 2006, Cancer.

[25]  M. Dewhirst,et al.  Expression of HIF-1α, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer , 2005 .

[26]  Elisa Rossi,et al.  Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer. , 2005, Journal of the National Cancer Institute.

[27]  R. Haba,et al.  Clinical application of biological markers for treatments of resectable non-small-cell lung cancers , 2005, British Journal of Cancer.

[28]  Chan Zeng,et al.  Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  R. Pötter,et al.  Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[30]  Markus Bredel,et al.  Vascular Patterns in Glioblastoma Influence Clinical Outcome and Associate with Variable Expression of Angiogenic Proteins: Evidence for Distinct Angiogenic Subtypes , 2003, Brain pathology.

[31]  S. Lange,et al.  Adjusting for multiple testing--when and how? , 2001, Journal of clinical epidemiology.

[32]  Harald Heinzl,et al.  Using SAS to calculate the Kent and O'Quigley measure of dependence for Cox proportional hazards regression model , 2000, Comput. Methods Programs Biomed..

[33]  D A Hilton,et al.  Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. , 1999, Cancer research.

[34]  C. Nieder,et al.  Patterns of relapse and late toxicity after resection and whole-brain radiotherapy for solitary brain metastases , 1998, Strahlentherapie und Onkologie.

[35]  M Buyse,et al.  Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. , 1997, The American journal of pathology.

[36]  L Gaspar,et al.  Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. , 1997, International journal of radiation oncology, biology, physics.

[37]  A. Harris,et al.  PROGNOSTIC VALUE OF ANGIOGENESIS IN OPERABLE NON‐SMALL CELL LUNG CANCER , 1996, The Journal of pathology.

[38]  John T. Kent,et al.  Measures of dependence for censored survival data , 1988 .

[39]  D. Kondziolka,et al.  Leukoencephalopathy after whole‐brain radiation therapy plus radiosurgery versus radiosurgery alone for metastatic lung cancer , 2013, Cancer.

[40]  L. Collette,et al.  A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  Jochen Herms,et al.  Real-time imaging reveals the single steps of brain metastasis formation , 2010, Nature Medicine.

[42]  N. Weidner,et al.  Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors , 2004, Breast Cancer Research and Treatment.

[43]  F. Mangili,et al.  Cell loss and proliferation in non-small cell lung carcinoma: correlation with histological subtype. , 1998, European journal of histochemistry : EJH.